Venor Pharma Limited Morphine Export Data — India (DGFT 2022–2026)

Name: Venor Pharma Limited Morphine Export Records India — #2 Exporter, 182 Shipments, $4.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Morphine

India Pharmaceutical Trade Intelligence

$17.8M16 Suppliers51 CountriesHS 30049099

ExportsIndia → BOTSWANA64.5%India → SRI LANKA14.9%

ImportsUNITED STATES → India$252.9K CANADA → India$8.8K

#1 Supplier: MEDWISE OVERSEAS #1 Buyer: STATE PHARMACEUTICALS

Venor Pharma Limited — Morphine Exporter #2 | $4.4M Trade Value | TransData Nexus | TransData Nexus

Venor Pharma Limited — Morphine Exporter Profile

Indian Pharmaceutical Exporter · #2 for Morphine · $4.4M export value · DGFT Verified

Venor Pharma Limited is the #2 Indian exporter of Morphine with $4.4M in export value and 182 verified shipments. Venor Pharma Limited holds a 24.5% market share in Morphine exports across 33 countries. The company exports 9 pharmaceutical products worth $8.6M across 4 therapeutic categories.

Venor Pharma Limited — Morphine Export Profile: Buyers & Destinations

Venor Pharma Limited Morphine export treemap — buyers and destination countries | TransData Nexus

Where Does Venor Pharma Limited Export Morphine?

Country	Value	Shipments	Share
SRI LANKA	$1.4M	40	46.2%
COSTA RICA	$390.5K	14	13.2%
GUYANA	$175.0K	13	5.9%
SENEGAL	$142.2K	9	4.8%

Who Are the Top Buyers of Morphine from Venor Pharma Limited?

Buyer	Country	Value	Orders
TO THE ORDER OF	SENEGAL	$1.7M	94
STATE PHARMACEUTICALS CORPORATION	SRI LANKA	$372.6K	8
M/S.PHARMACIE NATIONALE	SENEGAL	$108.3K	4
M/S NEW GPC INC	GUYANA	$101.1K	4
JAFFAR PHARMACY	BAHRAIN	$93.7K	2
TO THE ORDER	COSTA RICA	$82.8K	3
DROGUERIA ALMACEN GENERAL C.C.S.S	COSTA RICA	$50.0K	1
M/S DELMA PHARMA LIMITED	GHANA	$43.6K	1
M/S BEREKO PHARMA	SIERRA LEONA	$41.2K	3
AL-HOBAIL MEDICAL OFFICE COMPANY	SAUDI ARABIA	$35.5K	4

Venor Pharma Limited supplies Morphine to 42 buyers globally. The largest buyer is TO THE ORDER OF (SENEGAL), followed by STATE PHARMACEUTICALS CORPORATION (SRI LANKA) and M/S.PHARMACIE NATIONALE (SENEGAL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Morphine Formulations Does Venor Pharma Limited Export?

Product Description / Formulation	Value	Shipments
MORPHINE SULPHATE INJ BP 2MG/2ML AMP(VER	$200.0K	4
BRAND.VERMOR SR-30 TAB.MORPHINE SULPHATE	$108.3K	4
BRAND.VERMOR INJ.MORPHINE SULPHATE BP 10	$93.7K	2
VERMOR INJ.MORPHINE SULPHATE BP 10MG/ML,	$67.2K	6
BRAND VERMOR SR-30 TAB MORPHINE SULPHATE	$63.7K	2
PHARMACEUTICALS:MORPHINE SULPHATE INJECTION BP 15MG/ML,1ML AMP.(VERMOR-15)BN.EN042516,EN042517 MD.MAR. 2025 ED.FEB. 2027	$54.6K	2
TAB.MORPHINE SULPHATE BP 20MG BN.EN22220	$50.0K	1
MORPHINE SULPHATE INJECTION BP 15MG/ML,1	$50.0K	1
MORPHINE SULPHATE TABLETS BP 10 MG (MORV	$50.0K	1
MORPHINE SULPHATE TAB BP 10 MG (MORVER-1	$50.0K	1

Venor Pharma Limited exports 126 distinct Morphine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MORPHINE SULPHATE INJ BP 2MG/2ML AMP(VER with 4 shipments worth $200.0K.

How Does Venor Pharma Limited Compare to Nearest Morphine Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	VENOR PHARMA LIMITED ★	$4.4M	182	33	$24.0K
3	RUSAN PHARMA LIMITED	$545.4K	17	8	$32.1K
4	VERVE HUMAN CARE LABORATORIES	$367.6K	19	14	$19.3K

Venor Pharma Limited ranks #2 among 16 Indian Morphine exporters. Average shipment value of $24.0K compared to the market average of $394.6K. The closest competitors by value are RUSAN PHARMA LIMITED and VERVE HUMAN CARE LABORATORIES.

Which Indian Ports Ship Morphine Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	115	39.7%
DELHI AIR	95	32.8%
Delhi Air	13	4.5%
Delhi Air Cargo	12	4.1%
SAHAR AIR	11	3.8%
SAHAR AIR CARGO ACC (INBOM4)	9	3.1%
NHAVA SHEVA SEA (INNSA1)	5	1.7%
CHENNAI SEA (INMAA1)	3	1.0%

Geopolitical & Trade Policy Impact on Venor Pharma Limited's Morphine Exports

Recent geopolitical developments have introduced significant challenges for Indian pharmaceutical exporters like Venor Pharma. The escalation of conflicts in the Middle East, particularly the Red Sea crisis, has led to disruptions in key shipping routes. Major carriers have suspended or restricted transits through the Strait of Hormuz and the Red Sea–Suez Canal corridor, resulting in extended transit times by 10–20 days and increased freight rates by 40–50% on India–Europe routes. (livemint.com) These disruptions are particularly concerning for time-sensitive pharmaceutical shipments, potentially affecting the timely delivery of products like Diazepam and Fentanyl.

In the United States, recent trade policies have introduced additional complexities. The imposition of a 25% reciprocal tariff on Indian imports, effective August 2025, and the subsequent increase to a 50% tariff linked to India's energy trade decisions, have raised concerns about the cost competitiveness of Indian pharmaceutical products in the U.S. market. (en.wikipedia.org) While pharmaceuticals have been largely exempt from these tariffs, the potential for future policy shifts necessitates vigilance.

The European Union's implementation of the Falsified Medicines Directive (FMD) has also impacted Indian exporters. Compliance with stringent serialization and traceability requirements has increased operational costs. For companies like Venor Pharma, ensuring adherence to these regulations is crucial to maintain market access and competitiveness in the EU.

Venor Pharma Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA, WHO, and EU authorities enforcing stringent Good Manufacturing Practice (GMP) standards. Instances such as the FDA's warning letter and import alert issued to Viatris' facility in Indore, India, in December 2024, highlight the critical importance of compliance. (en.wikipedia.org) For Venor Pharma, maintaining impeccable quality standards and regulatory compliance is essential to avoid similar setbacks and to sustain its export operations.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Morphine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Venor Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 182 individual customs records matching Venor Pharma Limited exporting Morphine, covering 126 formulations to 34 countries via 42 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 51+ countries, 101+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Morphine

Morphine

Venor Pharma Limited — Morphine Exporter Profile

Venor Pharma Limited — Morphine Export Profile: Buyers & Destinations

Where Does Venor Pharma Limited Export Morphine?

Who Are the Top Buyers of Morphine from Venor Pharma Limited?

What Is India's Total Morphine Export Value and How Much Does Venor Pharma Limited Contribute?

What Is the Average Shipment Value for Venor Pharma Limited's Morphine Exports?

How Does Venor Pharma Limited Compare to Other Indian Morphine Exporters?

What Morphine Formulations Does Venor Pharma Limited Export?

How Does Venor Pharma Limited Compare to Nearest Morphine Exporters?

Which Indian Ports Ship Morphine Exports?

What Other Analgesics & Antipyretics Products Does Venor Pharma Limited Export?

Geopolitical & Trade Policy Impact on Venor Pharma Limited's Morphine Exports

Venor Pharma Limited — Regulatory Compliance & Quality Standards

About Venor Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Morphine Export Data from Venor Pharma Limited

Morphine Stats

Company Overview

Top Products by Venor Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source